Skip to main content
Canna~Fangled Abstracts

The basolateral amygdala γ-aminobutyric acidergic system in health and disease.

By November 19, 2015No Comments
 2015 Nov 19. doi: 10.1002/jnr.23690. [Epub ahead of print]
Prager EM1, Bergstrom HC2, Wynn GH3,4,5, Braga MF1,3,4,5.

Abstract

PM 1aThe brain comprises an excitatory/inhibitory neuronal network that maintains a finely tuned balance of activity critical for normal functioning. Excitatory activity in the basolateral amygdala (BLA), a brain region that plays a central role in emotion and motivational processing, is tightly regulated by a relatively small population of γ-aminobutyric acid (GABA) inhibitory neurons. Disruption in GABAergic inhibition in the BLA can occur when there is a loss of local GABAergic interneurons, an alteration in GABAA receptor activation, or a dysregulation of mechanisms that modulate BLA GABAergic inhibition. Disruptions in GABAergic control of the BLA emerge during development, in aging populations, or after trauma, ultimately resulting in hyperexcitability. BLA hyperexcitability manifests behaviorally as an increase in anxiety, emotional dysregulation, or development of seizure activity. This Review discusses the anatomy, development, and physiology of the GABAergic system in the BLA and circuits that modulate GABAergic inhibition, including the dopaminergic, serotonergic, noradrenergic, and cholinergic systems. We highlight how alterations in various neurotransmitter receptors, including the acid-sensing ion channel 1a, cannabinoid receptor 1, and glutamate receptor subtypes, expressed on BLA interneurons, modulate GABAergic transmission and how defects of these systems affect inhibitory tonus within the BLA. Finally, we discuss alterations in the BLA GABAergic system in neurodevelopmental (autism/fragile X syndrome) and neurodegenerative (Alzheimer’s disease) diseases and after the development of epilepsy, anxiety, and traumatic brain injury. A more complete understanding of the intrinsic excitatory/inhibitory circuit balance of the amygdala and how imbalances in inhibitory control contribute to excessive BLA excitability will guide the development of novel therapeutic approaches in neuropsychiatric diseases. © 2015 Wiley Periodicals, Inc.
© 2015 Wiley Periodicals, Inc.

KEYWORDS:

Alzheimer’s disease; GABA; anxiety; autism; basolateral amygdala; epilepsy

PMID:

 

26586374

 

[PubMed – as supplied by publisher]

Publication Types

Publication Types

twin memes II